Drug Discovery & Development Virtual Event Series 2025

This year's tracks and topics include:

Emerging Modalities in Drug Discovery and Preclinical Development

Microphysiological Systems
Emerging Assays
Advancements in Antibody-Drug Conjugates (ADCs)

Laboratory QA/QC

Animal Reduction in Preclinical Drug Development (the 3Rs)
In-vitro Models of Toxicity
Predicting Safety and Efficacy

Advancing the Art: Improving Drug Discovery & Delivery Methodology

Pharmacogenetics, Pharmacogenomics and Precision Medicine
AI and Machine Learning in Drug Discovery
Next-Generation Therapeutics

Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2025 Drug Discovery & Development Virtual Event. Submission is free. Submit your abstract here.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 1 year from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global drug discovery community with a high degree of interaction through live-streaming video and chat sessions.

Connect with us!
When you attend the event remember to use the hashtag #LRdrug to follow the conversation and connect with other members of the global Drug Discovery & Development community! Follow @DrugDiscoveryLR on Twitter and @DrugDiscoveryandDevelopment on Facebook to connect with our specialist Drug Discovery & Development writers and stay up to date with the latest Trending News in Drug Discovery & Development.

You can now also join our Drug Discovery, Development, & Therapeutics professional networking group on LinkedIn!

Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.

Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.

Volkmar Weissig, ScD, PhD, MS, BS

Professor of Pharmacology (tenured) and Biomedical Sciences, Midwestern University

BIOGRAPHY

SEE ABSTRACT | Continuing Education: P.A.C.E. CE | Florida CE

Liposomes were formulated for the first time at the beginning of the 1960s, exosomes were named as such at the beginning of the 1980s. Liposomes have been extensively explored as a drug delivery system for 50+ years, and exosomes have been systematically studied for their essential and multifaceted roles in cell biology, physiology and disease for over 40 years. More recently, exosomes came into the spotlight as a potential drug delivery system, based among others on their biocompatibility, low-toxicity and low immunogenicity, which are essential features they have in common with liposomes. The first liposomal drug was FDA approved in 1995, currently there are over 15 liposome-based nanomedicines in the clinic. On the way towards drug approval, Liposomologists had to solve numerous problems which are currently also being discussed by researchers who are trying to utilize exosomes as a drug delivery system. Such problems involve basic pharmacokinetic issues, like absorption, distribution and clearance, further efficient drug loading, vesicle stability, surface modifications (leading to potential immunogenicity) and finally all aspects associated with pharmaceutical manufacturing including appropriate methods for vesicle characterization. This presentation will first give an overview about the biogenesis and classification of exosomes as well as about their multitude of physiological functions followed by a focus on lessons learned in the history of over 50 years of Liposome Technology, which should be heeded by new investigators who are exploring exosomes as a drug delivery system.

Learning Objectives:

1. Explain biogenesis, classifcation and physiological functions of exosomes and extracellular vesicles.

2. Discuss the multitude of challenges associated with the translation of exosomes and extracellular vesicles into the clinic.

3. Interpret the lessons learned from the development of FDA-approved liposomal drugs.

CE Credits

The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here

Drug Discovery & Development Virtual Event Series 2025

This year's tracks and topics include:

Bala Addepalli, PhD

Dr. Shoaib Iqbal

Medha D. Joshi, B. Pharm, M. Pharm, PhD

Nhu-An Pham, PhD

Helen E. Smith, PhD

Rachita Sumbria, PhD

Volkmar Weissig, ScD, PhD, MS, BS

Agenda Share

Wed Feb 19

Topics

Keynote Presentation: Exosomes versus Liposomes as Next Generation Therapeutics with Live Q&A

Keynote Presentation: Exosomes versus Liposomes as Next Generation Therapeutics with Live Q&A

Speakers Share

Bala Addepalli, PhD

Dr. Shoaib Iqbal

Medha D. Joshi, B. Pharm, M. Pharm, PhD

Nhu-An Pham, PhD

Helen E. Smith, PhD

Rachita Sumbria, PhD

Volkmar Weissig, ScD, PhD, MS, BS

Sponsors & Partners Share

CE Credits Share

Keynote Presentation: Exosomes versus Liposomes as Next...

Event Series

Drug Discovery & Development Virtual Event Series 2024

Drug Discovery & Development Virtual Event Series 2023

Drug Discovery & Development Virtual Event Series 2022

Drug Discovery & Development Virtual Event Series 2021

Drug Discovery & Development Virtual Event Series 2020

Drug Discovery Virtual Event Series 2019

Drug Discovery Virtual Event Series 2018

Drug Discovery & Development Virtual Event Series 2025

This year's tracks and topics include:

Bala Addepalli, PhD

Dr. Shoaib Iqbal

Medha D. Joshi, B. Pharm, M. Pharm, PhD

Nhu-An Pham, PhD

Helen E. Smith, PhD

Rachita Sumbria, PhD

Volkmar Weissig, ScD, PhD, MS, BS

Agenda Share // Get the id and entity for ajax statistics window.entity = 'VirtualEvent'; window.entityId = '8551';

Speakers Share // Get the id and entity for ajax statistics window.entity = 'VirtualEvent'; window.entityId = '8551';

Bala Addepalli, PhD

Dr. Shoaib Iqbal

Medha D. Joshi, B. Pharm, M. Pharm, PhD

Nhu-An Pham, PhD

Helen E. Smith, PhD

Rachita Sumbria, PhD

Volkmar Weissig, ScD, PhD, MS, BS

Sponsors & Partners Share // Get the id and entity for ajax statistics window.entity = 'VirtualEvent'; window.entityId = '8551';

CE Credits Share // Get the id and entity for ajax statistics window.entity = 'VirtualEvent'; window.entityId = '8551';

Event Series

Agenda Share

Speakers Share

Sponsors & Partners Share

CE Credits Share